1. Home
  2. CRL vs XPEV Comparison

CRL vs XPEV Comparison

Compare CRL & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

N/A

Current Price

$288.50

Market Cap

10.8B

Sector

Health Care

ML Signal

N/A

Logo XPeng Inc.

XPEV

XPeng Inc.

N/A

Current Price

$10.95

Market Cap

12.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
CRL
XPEV
Founded
1947
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
12.5B
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
CRL
XPEV
Price
$288.50
$10.95
Analyst Decision
Buy
Buy
Analyst Count
12
5
Target Price
$198.27
$23.08
AVG Volume (30 Days)
848.5K
6.6M
Earning Date
05-07-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,857,601,000.00
N/A
Revenue This Year
N/A
$25.76
Revenue Next Year
$3.04
$25.98
P/E Ratio
N/A
N/A
Revenue Growth
10.48
N/A
52 Week Low
$144.26
$10.72
52 Week High
$303.31
$28.20

Technical Indicators

Market Signals
Indicator
CRL
XPEV
Relative Strength Index (RSI) 61.92 38.64
Support Level $215.89 N/A
Resistance Level $303.31 $12.33
Average True Range (ATR) 9.54 0.39
MACD -2.67 -0.01
Stochastic Oscillator 43.54 28.54

Price Performance

Historical Comparison
CRL
XPEV

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About XPEV XPeng Inc.

Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Share on Social Networks: